Iridex Corporation (NASDAQ:IRIX)

Tuesday, November 7, 2023

Research

Iridex Corporation (NASDAQ:IRIX)($2.40; $38.9M market cap - On October 20, 2023 we highlighted Geoinvesting Premium Subscriber Mark Gomes' case that IRIX, an ophthalmic medical technology company that provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases. 

Mark posited that the stock could increase significantly on a possible asset sale. 

On November 1, 2023 we mentioned that changes to health insurance coverage determination for part of IRIX’s procedures led the company to withdraw its annual guidance, and the stock was negatively impacted. 

Mark provided a very detailed video explanation of what he feels is a major overreaction by the market to the news. You can see the full video here



Market Data powered by QuoteMedia. Terms of Use